PRINCIPAL FINANCIAL GROUP INC

Position in KROS — Keros Therapeutics, Inc.

CIK 1126328 DES MOINES, IA

Position in KROS

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$682,734

+$24,817 QoQ

Shares Held

63,807

+7.1% QoQ

Ownership

0.322%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 131 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. KROS ranks #59 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	873,502	$232,980,453
2	VRTX	Vertex Pharmaceuticals Inc / Ma	389,511	$193,481,798
3	CYTK	Cytokinetics Inc	1,311,664	$111,740,655
4	GPCR	Structure Therapeutics Inc.	1,752,753	$94,070,253
5	INSM	INSMED Inc	856,126	$91,280,154
6	AXSM	Axsome Therapeutics, Inc.	332,642	$81,420,782
7	BBIO	BridgeBio Pharma, Inc.	1,024,423	$76,299,024
8	REGN	Regeneron Pharmaceuticals, Inc.	121,053	$75,481,386

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$682,734	63,807	+7.1%	Shares	Defined	2026-08-04
2026-03-31	$657,917	59,594	+1031.9%	Shares	Defined	2026-05-04
2024-06-30	$240,610	5,265	-25.5%	Shares	Defined	2024-07-29
2024-03-31	$467,570	7,063	+8.8%	Shares	Defined	2024-04-29
2023-12-31	$258,002	6,489	-0.4%	Shares	Defined	2024-02-07
2023-09-30	$207,601	6,512	-1.5%	Shares	Defined	2023-11-02
2023-06-30	$265,669	6,612	+12.5%	Shares	Defined	2023-08-07
2023-03-31	$250,947	5,877	-6.4%	Shares	Defined	2023-05-09
2022-12-31	$301,420	6,277	+99.9%	Shares	Defined	2023-02-09
2020-12-31	$221,495	3,140	—	Shares	Defined	2021-02-23
No filing history on record for this holder in this stock.